Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC).
Thomas Powles
Consultant or Advisory Role - Genentech; GlaxoSmithKline
Nicholas J. Vogelzang
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Celgene
Honoraria - Pfizer
Research Funding - Novartis
Gregg Daniel Fine
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Joseph Paul Eder
No relevant relationships to disclose
Fadi S. Braiteh
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Roche
Yohann Loriot
No relevant relationships to disclose
Cristina Cruz Zambrano
No relevant relationships to disclose
Joaquim Bellmunt
Consultant or Advisory Role - Genentech (U)
Howard A. Burris
No relevant relationships to disclose
Siew-leng Melinda Teng
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Xiaodong Shen
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Hartmut Koeppen
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Priti S. Hegde
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Daniel S. Chen
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Daniel Peter Petrylak
Honoraria - Genentech